Schroders’s Edwards Lifesciences EW Stock Holding History

Schroders’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,132	Closed	-$393K	–	35
2022 Q2	$393K	Sell	4,132 -2,363	-36%	-$245K	0.11%	28
2022 Q1	$765K	Buy	+6,495	New	+$729K	0.17%	24

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Schroders's EW Position: Q3 2022 in Review

Schroders sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 4,132 shares — an estimated $393K sold.

Schroders first reported a position in EW in Q1 2022 and held it in 2 quarters. The position peaked at $765K in Q1 2022. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Schroders reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
Schroders sold 4,132 Edwards Lifesciences shares in Q3 2022, an estimated $393K.
Schroders first reported a position in Edwards Lifesciences in Q1 2022 and held it in 2 quarters.
Schroders's Edwards Lifesciences position peaked at $765K in Q1 2022.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Schroders's 13F filing for Q3 2022, filed 24 Oct 2022.